Ken Masubuchi

机构：Gunma Children's Medical Center, Hyogo Prefectural Cancer Center, Gunma Prefectural Cancer Center · ORCID：0000-0001-7440-441X

发表论文 37 篇 · 总被引 218 次 · h-index 8

代表论文

• C-Jun-NH2-Terminal Kinase Mediates Expression of Connective Tissue Growth Factor Induced by Transforming Growth Factor-β1 in Human Lung Fibroblasts (2003 · American Journal of Respiratory Cell and Molecular Biology · 被引 89)
• Glutathione redox regulates TGF‐β‐induced fibrogenic effects through Smad3 activation (2008 · FEBS Letters · 被引 25)
• A Prospective Phase II Trial of First-Line Osimertinib for Patients With EGFR Mutation-Positive NSCLC and Poor Performance Status (OPEN/TORG2040) (2025 · Journal of Thoracic Oncology · 被引 16)
• Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival (2021 · Thoracic Cancer · 被引 11)
• Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed (2023 · Thoracic Cancer · 被引 9)
• Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival (2022 · Thoracic Cancer · 被引 9)